Gainers & Losers
Mon Mar 16 2026 09:55:51- UltraTech Cement share price
- ₹11,079.004.45%
- Mahindra & Mahindra Ltd share price
- ₹3,036.952.91%
- Eternal share price
- ₹221.802.69%
- Trent share price
- ₹3,580.002.57%
- HDFC Bank share price
- ₹836.452.38%
Active Stocks
Mon Mar 16 2026 02:20:01- Yes Bank share price
- ₹18.55-1.38%
- Adani Power share price
- ₹154.105.04%
- Suzlon Energy share price
- ₹41.01-0.94%
- Max Healthcare Institute share price
- ₹970.05-2.02%
- Oil and Natural Gas Corpor...
- ₹260.40-2.01%
Business News/Market/Market Stats/Alembic Pharmaceuticals share price/ Alembic Pharmaceuticals Profit Loss Annual
Alembic Pharmaceuticals Profit & Loss Annual
673.60 -10.80 (-1.59%)Updated : 16 Mar 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 5,929.40 | 5,567.90 | 5,214.84 | 4,718.33 |
| Other Net | 8.32 | 2.39 | 1.61 | 0.93 |
| Diluted Weighted Average Shares | 19.66 | 19.66 | 19.66 | 19.66 |
| Gain( Loss)on Saleof Assets | 3.26 | 1.70 | -4.70 | 0.54 |
| Depreciation/ Amortization | 278.58 | 272.67 | 275.43 | 286.78 |
| Operating Income | 742.68 | 660.73 | 437.78 | 587.46 |
| Net Income | 583.42 | 615.83 | 341.98 | 520.93 |
| Income Availableto Com Excl Extra Ord | 583.42 | 615.82 | 341.99 | 520.94 |
| Other Operating Expenses Total | 26.07 | 21.40 | 17.57 | 12.67 |
| Net Income Before Taxes | 707.18 | 631.83 | 354.59 | 620.11 |
| Minority Interest | 1.41 | - | - | - |
| Net Income After Taxes | 582.01 | 615.83 | 341.98 | 515.65 |
| Income Availableto Com Incl Extra Ord | 583.42 | 615.82 | 341.99 | 520.94 |
| Costof Revenue Total | 2,316.60 | 2,174.07 | 2,174.70 | 1,844.03 |
| Gross Profit | 4,355.48 | 4,054.56 | 3,477.92 | 3,461.76 |
| Interest Inc( Exp) Net- Non- Op Total | -47.08 | -32.99 | -80.10 | 31.18 |
| Unusual Expense( Income) | -12.87 | 0.00 | 0.00 | - |
| Diluted Net Income | 583.42 | 615.82 | 341.99 | 520.94 |
| DPS- Common Stock Primary Issue | 11.00 | 11.00 | 8.00 | 10.00 |
| Provisionfor Income Taxes | 125.17 | 16.00 | 12.61 | 104.46 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 583.42 | 615.83 | 341.98 | 520.93 |
| Total Revenue | 6,672.08 | 6,228.63 | 5,652.62 | 5,305.79 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 6,672.08 | 6,228.63 | 5,652.62 | 5,305.79 |
| Selling/ General/ Admin Expenses Total | 2,869.81 | 2,715.31 | 2,178.21 | 1,945.86 |
| Diluted Normalized EPS | 29.01 | 31.25 | 17.63 | 26.48 |
| Research Development | 451.21 | 384.45 | 568.93 | 628.99 |
| Diluted EPS Excluding Extra Ord Items | 29.68 | 31.33 | 17.40 | 26.50 |
| Total Adjustmentsto Net Income | - | -0.10 | 0.10 | 0.10 |
| Equity In Affiliates | - | - | - | 5.28 |
*All figures in crores except per share values
Alembic Pharmaceuticals Quick Links
Alembic Pharmaceuticals Dividend Alembic Pharmaceuticals Bonus Alembic Pharmaceuticals News Alembic Pharmaceuticals AGM Alembic Pharmaceuticals Rights Alembic Pharmaceuticals Splits Alembic Pharmaceuticals Board Meetings Alembic Pharmaceuticals Key Metrics Alembic Pharmaceuticals Shareholdings Alembic Pharmaceuticals Balance Sheet Alembic Pharmaceuticals Cashflow Alembic Pharmaceuticals Q1 Results Alembic Pharmaceuticals Q2 Results Alembic Pharmaceuticals Q3 Results Alembic Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
2,184.40+48.95(2.29%)
3,568.35+36.20(1.02%)
1,814.30+13.50(0.75%)
3,575.85-145.10 (-3.90%)
186.35-7.10 (-3.67%)